Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Pharmaceutical Design|September 23, 2010
New anticoagulants for the prevention of thromboembolismKylie Lepic, Mark CrowtherCurrent Opinion in Hematology|June 25, 2009
A logical approach to surgical thromboprophylaxisKylie Lepic, Mark A CrowtherJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 9, 2026
Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology ResidentsGrace Zhang, Dong Audrey, Kylie Lepic, et al.Hematology (Amsterdam, Netherlands)|June 23, 2025
Revaccination following CAR-T therapy: a needs assessmentRobert Clayden, Barbara Gunka, Brittany Salter, et al.Transplantation and Cellular Therapy|June 21, 2021
Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in CanadaSylvie Lachance, Marcio M Gomes, Nadia M Bambace, et al.Current Oncology (Toronto, Ont.)|February 25, 2025
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin LymphomaShiliang Ge, Kylie Lepic, Ravi Bhindi, et al.Ejhaem|October 30, 2025
Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective AnalysisJoanne Britto, Audrey Y H Dong, Gregory Pond, et al.Transplantation and Cellular Therapy|November 15, 2024
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDSMichael Radford, Alejandro Garcia-Horton, Rohail Badami, et al.Transfusion|June 10, 2026
Changes in unrelated donor usage for allogeneic hematopoietic cell transplant in Canada: 2013-2023 and identifying priorities in donor selectionTanvir Hasan, Matthew Seftel, Patti Wright, et al.Current Oncology (Toronto, Ont.)|January 27, 2026
Abstracts of the Cell Therapy Transplant Canada 2024 Annual ConferenceStephanie A Maier, Frédéric Barabé, Tobias Berg, et al.Pageof 2